PA
GPRE icon

PharVision Advisers’s Green Plains GPRE Stock Holding History

PharVision Advisers’s Portfolio GPRE Stock Details GPRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,530
Closed -$289K – 332
2025
Q4 		$289K Sell
29,530
-16,869
-36% -$170K 0.15% 290
2025
Q3 		$408K Buy
+46,399
New +$407K 0.23% 75
2025
Q1 		– Sell
-32,906
Closed -$312K – 371
2024
Q4 		$312K Buy
+32,906
New +$371K 0.26% 140

Other funds holding GPRE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

PharVision Advisers's GPRE Position: Q1 2026 in Review

PharVision Advisers sold out of Green Plains (GPRE) in Q1 2026, closing a stake of 29,530 shares — an estimated $289K sold.

PharVision Advisers first reported a position in GPRE in Q4 2024 and held it in 3 quarters. The position peaked at $408K in Q3 2025. 205 funds tracked by Wall St. Rank hold GPRE as of Q1 2026.

  • PharVision Advisers reported no remaining Green Plains position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 29,530 Green Plains shares in Q1 2026, an estimated $289K.
  • PharVision Advisers first reported a position in Green Plains in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's Green Plains position peaked at $408K in Q3 2025.
  • 205 funds tracked by Wall St. Rank held Green Plains as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.